View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

A randomized, double-blind, placebo-controlled study evaluating Acetazolamide efficacy in ataxia in PMM2-CDG

PMM2 Acetazolamide Trial

Clinicaltrials.gov ID: NCT04679389

What is the goal of the study?

Multicenter, randomized, double-blind, placebo-controlled trial to determine the efficacy of acetazolamide in improving ataxia in patients with PMM2-CDG. 6 Subjects at our site will be randomized to placebo/Acetazolamide on a 1:1 ratio for 6 months then crossed over to open label treatment on Acetazolamide.

Who can participate in the study?

Everyone

Study Team:

PI (Study Doctor): Christina Lam
Study Team Member: Hayden Vreugdenhil, hayden.vreugdenhil@seattlechildrens.org